BR112023004550A2 - Compostos tricíclicos substituídos - Google Patents
Compostos tricíclicos substituídosInfo
- Publication number
- BR112023004550A2 BR112023004550A2 BR112023004550A BR112023004550A BR112023004550A2 BR 112023004550 A2 BR112023004550 A2 BR 112023004550A2 BR 112023004550 A BR112023004550 A BR 112023004550A BR 112023004550 A BR112023004550 A BR 112023004550A BR 112023004550 A2 BR112023004550 A2 BR 112023004550A2
- Authority
- BR
- Brazil
- Prior art keywords
- compounds
- substituted tricyclic
- tricyclic compounds
- formula
- alkyl group
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 229910003827 NRaRb Inorganic materials 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 229940043355 kinase inhibitor Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000003757 phosphotransferase inhibitor Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
Abstract
COMPOSTOS TRICÍCLICOS SUBSTITUÍDOS. A invenção fornece um composto de fórmula (I) ou um sal farmaceuticamente aceitável do mesmo; em que Q é um grupo de fórmula Q1 ou Q2; ligação ondulada representa os pontos de fixação; em que R1 é NRaRb; R2 é hidrogênio ou um grupo C1-C10 alquila; Ra e Rb representam independentemente hidrogênio ou um grupo C1-C10 alquila, e o uso destes compostos como inibidores de quinase e composições compreendendo os compostos da presente invenção.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN202021043852 | 2020-10-08 | ||
| PCT/IB2021/059150 WO2022074572A1 (en) | 2020-10-08 | 2021-10-06 | Substituted tricyclic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112023004550A2 true BR112023004550A2 (pt) | 2023-05-02 |
Family
ID=81126662
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112023004550A BR112023004550A2 (pt) | 2020-10-08 | 2021-10-06 | Compostos tricíclicos substituídos |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230374011A1 (pt) |
| EP (1) | EP4225442A1 (pt) |
| JP (1) | JP2023544678A (pt) |
| KR (1) | KR20230083270A (pt) |
| CN (1) | CN116547283A (pt) |
| AU (1) | AU2021357176A1 (pt) |
| BR (1) | BR112023004550A2 (pt) |
| CA (1) | CA3190745A1 (pt) |
| MX (1) | MX2023002620A (pt) |
| WO (1) | WO2022074572A1 (pt) |
| ZA (1) | ZA202303688B (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023194840A1 (en) * | 2022-04-05 | 2023-10-12 | Unichem Laboratories Limited | Substituted tricyclic compounds and their use in covid-19 |
| WO2023194842A1 (en) * | 2022-04-05 | 2023-10-12 | Unichem Laboratories Limited | Substituted tricyclic compounds and their use in rheumatoid arthritis |
| WO2023194841A1 (en) * | 2022-04-05 | 2023-10-12 | Unichem Laboratories Limited | Substituted tricyclic compounds and their use in ulcerative colitis |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7737279B2 (en) * | 2005-05-10 | 2010-06-15 | Bristol-Myers Squibb Company | 1,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same |
| PL2473510T3 (pl) * | 2009-09-03 | 2014-11-28 | Bristol Myers Squibb Co | Inhibitory JAK2 i ich zastosowanie do leczenia chorób mieloproliferacyjnych i nowotworu |
| WO2013007765A1 (en) * | 2011-07-13 | 2013-01-17 | F. Hoffmann-La Roche Ag | Fused tricyclic compounds for use as inhibitors of janus kinases |
-
2021
- 2021-10-06 CA CA3190745A patent/CA3190745A1/en active Pending
- 2021-10-06 CN CN202180067783.3A patent/CN116547283A/zh active Pending
- 2021-10-06 WO PCT/IB2021/059150 patent/WO2022074572A1/en active Application Filing
- 2021-10-06 JP JP2023512324A patent/JP2023544678A/ja active Pending
- 2021-10-06 KR KR1020237008116A patent/KR20230083270A/ko unknown
- 2021-10-06 BR BR112023004550A patent/BR112023004550A2/pt unknown
- 2021-10-06 EP EP21877106.1A patent/EP4225442A1/en active Pending
- 2021-10-06 AU AU2021357176A patent/AU2021357176A1/en active Pending
- 2021-10-06 US US18/030,583 patent/US20230374011A1/en active Pending
- 2021-10-06 MX MX2023002620A patent/MX2023002620A/es unknown
-
2023
- 2023-03-17 ZA ZA2023/03688A patent/ZA202303688B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA202303688B (en) | 2023-04-26 |
| US20230374011A1 (en) | 2023-11-23 |
| CA3190745A1 (en) | 2022-04-14 |
| WO2022074572A1 (en) | 2022-04-14 |
| EP4225442A1 (en) | 2023-08-16 |
| AU2021357176A1 (en) | 2023-06-08 |
| JP2023544678A (ja) | 2023-10-25 |
| CN116547283A (zh) | 2023-08-04 |
| MX2023002620A (es) | 2023-03-17 |
| KR20230083270A (ko) | 2023-06-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112023004550A2 (pt) | Compostos tricíclicos substituídos | |
| UY38076A (es) | Derivados de tetrahidroquinazolina útiles como agentes anticáncer | |
| UY37795A (es) | Sulfonilureas y sulfoniltioureas útiles como inhibidores de nlrp3 | |
| BR112021021718A2 (pt) | Moduladores de thr-ss e métodos de uso dos mesmos | |
| CO2021000808A2 (es) | Agente profiláctico o terapéutico para atrofia muscular espinal | |
| BRPI0413283B8 (pt) | Composto derivado de (tio)carbamoil-ciclohexano, seu processo de preparação, amina, composição farmacêutica e uso do composto | |
| CL2021001877A1 (es) | Compuestos moduladores de fxr (nr1h4) | |
| BR112021019643A2 (pt) | Compostos de pirazolopiridina como inibidores do ret e uso dos mesmos | |
| BR112016000127A8 (pt) | compostos bicíclicos úteis para tratar doenças causadas por retrovírus | |
| BRPI0718966B8 (pt) | composto, composição farmacêutica, inibidor plk1 e agente antitumoral | |
| AR077849A2 (es) | Compuestos y composiciones como inhibidores de proteina quinasa | |
| BRPI1010768C8 (pt) | composto de fórmula (i) | |
| AR117916A1 (es) | Compuesto heterocíclico y su uso | |
| BRPI0606905A2 (pt) | derivados de quinazolina tendo atividade inibitória de tirosina cinase e composição farmacêutica contendo-os | |
| BR112013001341A2 (pt) | compostos de pirimidina como inibidores de proteínas quinases ikk épsilon e/ou tbk-1, processo para a preparação dos mesmos e suas composições farmacêuticas | |
| RS51919B (en) | BENZOTIAZEPINE DERIVATIVES AND THEIR USE AS AMP AND NMDA RECEPTOR MODULATORS | |
| MA41337A (fr) | Dérivés de l'hydroxyalkyl pipérazine utilisés comme modulateurs du récepteur cxcr3 | |
| CL2022003646A1 (es) | Derivados de amidopirimidona | |
| BR112012005902A2 (pt) | formulação de catalisador de quelato de ti, uso da formulação de catalisador de quelato de ti ou de um composto, composição, processo para a polimeração de compostos, catalisador de quelato de ti, uso da composição polimerizável, e, substrato revestido | |
| CL2020002217A1 (es) | Uso de alcoxipirazoles como inhibidores de la nitrificación | |
| ECSP22027784A (es) | Derivados de 2azaespiro[3.4]octano como agonistas de m4 | |
| CL2022000893A1 (es) | Derivados de 2-azaspiro[3,4]octano como agonistas de m4 | |
| BR112021023635A2 (pt) | Novos compostos para inibição de janus quinase 1 | |
| MY195576A (en) | Novel Amino-Imidazopyridine Derivatives as Janus Kinase Inhibitors and Pharmaceutical use Thereof | |
| AR089014A1 (es) | Antihelminticos de sulfonamida |